Addex Therapeutics Ltd
NASDAQ:ADXN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Addex Therapeutics Ltd
NASDAQ:ADXN
|
CH |
|
Aura Biosciences Inc
NASDAQ:AURA
|
US |
|
M
|
Mosaic Co
BMV:MOS
|
US |
|
Q
|
Quantum eMotion Corp
XTSX:QNC
|
CA |
|
C
|
Coeur Mining Inc
DUS:CDM1
|
US |
|
BrainChip Holdings Ltd
F:24Y
|
AU |
|
D
|
DuoBack Co Ltd
KOSDAQ:073190
|
KR |
|
P
|
Puma SE
OTC:PUMSY
|
DE |
|
H
|
HFR Inc
KOSDAQ:230240
|
KR |
|
D
|
Datatec Ltd
JSE:DTC
|
ZA |
Intrinsic Value
Is ADXN undervalued or overvalued?
See the intrinsic value estimate for 
Addex Therapeutics Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Addex Therapeutics Does
Addex Therapeutics is a drug development company focused on medicines that act on G protein-coupled receptors, especially through a method called allosteric modulation. In plain English, it tries to make small-molecule drugs that fine-tune how receptors in the brain and body work, rather than simply switching them on or off. Its main work is centered on treatments for nervous system and inflammatory diseases, where receptor control can affect symptoms and disease pathways.
- Headquarters
- Switzerland CH
- Employees
- 3
- IPO date
- May 22, 2007
Revenue & Expenses Breakdown
Addex Therapeutics Ltd
Earnings Waterfall
Addex Therapeutics Ltd
The intrinsic value for Addex Therapeutics Ltd (ADXN) under the Base Case is hidden USD.
Compared with the current market price of 3.09 USD, the stock appears hidden.